{"id":68793,"date":"2013-08-28T11:13:03","date_gmt":"2013-08-28T10:13:03","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=2847"},"modified":"2013-08-28T11:13:03","modified_gmt":"2013-08-28T10:13:03","slug":"les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","title":{"rendered":"Las farmacias catalanas estudian monitorizar a pacientes cr\u00f3nicos"},"content":{"rendered":"<p><strong>El Consejo de Colegios Farmac\u00e9uticos de Catalu\u00f1a (CCFC) y el CatSalut est\u00e1n definiendo un<\/strong> <strong>plan piloto para poder realizar un seguimiento desde las farmacias de la evoluci\u00f3n de pacientes cr\u00f3nicos complejos<\/strong>. Se trata de pacientes con un historial de frecuentes ingresos hospitalarios, que sufren patolog\u00edas simult\u00e1neas y con un agarre a las terapias que no es \u00f3ptima. El m\u00e9dico de atenci\u00f3n primaria ser\u00e1 quien, si lo ve oportuno, derivar\u00e1 al paciente a su farmacia de referencia.<\/p>\n<p><strong><img fetchpriority=\"high\" decoding=\"async\" class=\"alignleft\" alt=\"spd\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/08\/spd.jpg\" width=\"306\" height=\"204\" \/><\/strong>El papel del farmac\u00e9utico se centrar\u00e1 en realizar el <strong>seguimiento farmacoterap\u00e9utico<\/strong> para controlar que la medicaci\u00f3n se toma adecuadamente y en la preparaci\u00f3n de sistemas personalizados de dosificaci\u00f3n (SPD). Los farmac\u00e9uticos que participen estar\u00e1n autorizados para prestar este servicio y se formar\u00e1n en la atenci\u00f3n a este tipo de pacientes complejos.<\/p>\n<p>Pilar Gasc\u00f3n, secretaria del Consell y tambi\u00e9n vocal de Investigaci\u00f3n y Docencia del Colegio de Farmac\u00e9uticos de Barcelona, ha comentado que la prueba piloto sigue en la l\u00ednea del objetivo por parte del colectivo de \u201chacer <strong>nuevas actuaciones profesionales fundamentadas en el conocimiento de los medicamentos del farmac\u00e9utico para que los pacientes obtengan el m\u00e1ximo beneficio de los tratamientos<\/strong> que siguen\u201d.<\/p>\n<p>La prueba piloto para comprobar la viabilidad del proyecto se iniciar\u00e1 previsiblemente antes de finalizar el 2013.<\/p>","protected":false},"excerpt":{"rendered":"<p>El Consejo de Colegios Farmac\u00e9uticos de Catalu\u00f1a (CCFC) y el CatSalut est\u00e1n definiendo un plan piloto para poder realizar un seguimiento desde las farmacias de la evoluci\u00f3n de pacientes cr\u00f3nicos complejos. Se trata de pacientes con un historial de frecuentes ingresos hospitalarios, que sufren patolog\u00edas simult\u00e1neas y con una adherencia [\u2026]<\/p>","protected":false},"author":1,"featured_media":2853,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,32],"tags":[64,147],"class_list":["post-68793","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-noticies-farmacia","tag-atencio-farmaceutica","tag-medicament"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-08-28T10:13:03+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics\",\"datePublished\":\"2013-08-28T10:13:03+00:00\",\"dateModified\":\"2013-08-28T10:13:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\"},\"wordCount\":241,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"Medicament\"],\"articleSection\":[\"Destacats\",\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\",\"name\":\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-08-28T10:13:03+00:00\",\"dateModified\":\"2013-08-28T10:13:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","og_locale":"es_ES","og_type":"article","og_title":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-08-28T10:13:03+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics","datePublished":"2013-08-28T10:13:03+00:00","dateModified":"2013-08-28T10:13:03+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/"},"wordCount":241,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","Medicament"],"articleSection":["Destacats","Not\u00edcies farm\u00e0cia"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","url":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/","name":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-08-28T10:13:03+00:00","dateModified":"2013-08-28T10:13:03+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/08\/28\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Les farm\u00e0cies catalanes estudien monitoritzar a pacients cr\u00f2nics"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":1,"uagb_excerpt":"El Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya (CCFC) i el CatSalut estan definint un pla pilot per poder fer un seguiment des de les farm\u00e0cies de l\u2019evoluci\u00f3 de pacients cr\u00f2nics complexos. Es tracta de pacients amb un historial de freq\u00fcents ingressos hospitalaris, que pateixen patologies simult\u00e0nies i amb una adher\u00e8ncia [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/68793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=68793"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/68793\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=68793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=68793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=68793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}